WallStreetZenWallStreetZen

How to Buy Charles River Laboratories International Stock

Charles River Laboratories International Inc

Charles River Laboratories International is a diagnostic & research company located in Massachusetts, United States, which is part of the Healthcare sector, and is traded under the ticker CRL on the NYSE exchange.

Charles River Laboratories International stock last closed at $201.82, up 1.91% from the previous day, and has decreased 28.93% in one year. It has underperformed other stocks in the Diagnostics & Research industry by 0.18 percentage points. Charles River Laboratories International stock is currently +11.28% from its 52-week low of $181.36, and -34.51% from its 52-week high of $308.15.

There are currently 50.99M shares of CRL outstanding. The market value of CRL is $10.29B. In the past 24 hours, 465,658 CRL shares were traded.

How to Buy Charles River Laboratories International Stock

Not sure how to invest in Charles River Laboratories International stock? Here's how.
  1. Choose where to buy Charles River Laboratories International stock: You need to pick an online brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you determine where to buy Charles River Laboratories International stock.
  2. Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
  3. Deposit funds into your investment account: Pick your method of payment and add your information.
  4. Evaluate Charles River Laboratories International stock: The Charles River Laboratories International ticker symbol is CRL. Is Charles River Laboratories International stock a good investment? Should you buy shares of CRL? How do CRL's underlying business fundamentals look? Do top analysts think Charles River Laboratories International is a good buy? Why has CRL's stock price moved recently? (Hint: Our stock market analysis website can help you understand if CRL is a good stock to buy).
  5. Make your CRL trade: Decide if you will purchase CRL shares at the current market price or use a limit order to buy CRL shares at a given price.
  6. Get notifications regarding your CRL investment: Create a watchlist to important notifications about your position in Charles River Laboratories International stock.

Step 1: Choose where to buy Charles River Laboratories International stock

You will need an online brokerage account to access the NYSE market and buy CRL stock.

A brokerage account is an investment account that allows you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

We believe that eToro is the best online stock brokerage. eToro gives you:

  • You can invest in stocks with zero commissions: Invest without commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
  • Access to world financial markets: From Tech to Real Estate, New York to Shanghai — you can fill your portfolio with stocks from the world's leading stock exchanges.
  • Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your purchase of shares by signing up for an account with eToro now.

Open eToro Account

Step 2: Open a brokerage account

Now that you've selected the right brokerage, the next step is to fill out some personal details so you are able to invest in CRL today.

How to Set Up a New Account on eToro

  1. Click here to get started.
  2. Provide your personal data to open your new brokerage account.
  1. Send your data by clicking the "Create Account" button.
Get started with eToro today

Step 3: Deposit funds into your investment account

Now that you've opened your account on the highest rated stock app, you need to deposit funds:

Watch the tutorial below to see the process of transferring funds into your investment account.

Get started with eToro today

Step 4: Evaluate Charles River Laboratories International stock

Once you have figured out the best place to buy Charles River Laboratories International stock, it's important to analyze their stock prior to buying, so you actually comprehend the risk and opportunity.

Charles River Laboratories International stock at a glance

CRL Price
$201.82
1w %
4.14%
1y %
-28.93%
5y %
95.73%
P/E
21.09x
P/B
3.46x
P/S
2.58x
PEG
0.97x
Revenue
$3.98B
Earnings
$486.23M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$10.29B
Next Earnings
May 2, 2023
Next Dividend
N/A

Fundamentals of Charles River Laboratories International

WallStreetZen was designed to help average investors do more accurate fundamental analysis.

You can view all of the due diligence checks on CRL's stock page.

Is CRL stock undervalued?

You can use a variety of different financial metrics, analyses, models, and charts to gauge CRL's true value.

Using relative valuations measures:

  • CRL could be undervalued based on its P/E ratio of 21.09x, relative to Diagnostics & Research industry P/E ratio of 33.78x
  • CRL may be undervalued based on its P/B ratio of 3.46x, relative to Diagnostics & Research industry P/B ratio of 4.28x
  • CRL may be undervalued based on its PEG ratio of 0.97x

You can access more valuation research on CRL's stock here.

A quick look at CRL Financials

Passed Health Checks:

  • There are more short-term assets than short-term liabilities on the CRL balance sheet.
  • CRL profit margin has gone up from 11% to 12.2% in the past year.
  • CRL earnings of $675.90M is not enough to cover its interest payments.
  • Total CRL debt is lower than 5 years ago, relative to shareholder equity.
  • CRL's operating cash flow of $619.64M allows it to safely service it's debt of $3.10B.

Failed Health Checks:

  • There are more long-term liabilities than short-term assets on the CRL balance sheet.
  • CRL has a relatively high debt to equity ratio of 1.54.

Is Charles River Laboratories International stock a Buy, Hold, or Sell, according to Wall Street analysts?

Out of 7 sell side analysts who track CRL, the consensus analyst rating on Charles River Laboratories International is a Buy

It's important to keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.

Most Recent CRL Analyst Recommendations

David Windley, a top 6% analyst from Jefferies maintains CRL with a hold rating and lowers their CRL price target from $233.00 to $203.00, on Mar 28, 2023.

Dan Leonard, a top 7% analyst from Credit Suisse maintains CRL with a buy rating and lowers their CRL price target from $280.00 to $260.00, on Feb 23, 2023.

Ricky Goldwasser, a top 4% analyst from Morgan Stanley maintains CRL with a hold rating and lowers their CRL price target from $241.00 to $230.00, on Feb 23, 2023.

Patrick B Donnelly, a top 6% analyst from Citigroup maintains CRL with a strong buy rating and lowers their CRL price target from $280.00 to $260.00, on Feb 23, 2023.

Sandy Draper, a top 9% analyst from Guggenheim upgrades CRL to a strong buy rating and announces their CRL price target of $255.00, on Feb 23, 2023.

You can dive deeper into what analysts are saying on the Charles River Laboratories International stock forecast page.

CRL Trading Indicators

SMA10
196.18
SMA20
201.66
SMA50
225.85
SMA100
226.19
SMA200
219.94
MACD
-7.95
MACD Signal
-9.48
MACD Histogram
1.53
RSI
44.56
Stochastic %K
46.08
Stochastic %D
32.59
StochRSI %K
100
StochRSI %D
86.93

CRL Growth Numbers

Last year, CRL earnings were $486.23M. In the past 5 year, CRL's earnings have grown by 29.77% per year. This was faster than the Diagnostics & Research industry average of 27.63%.

Last year, CRL revenue was $3.98B. During the last 5 year, CRL's revenue has gone up by 16.44% per year. This was faster than the Diagnostics & Research industry average of 16.32%.

Dive into CRL's earnings and revenue performance here.

Latest Insiders Trades at CRL

In the last 12 months, executives and large shareholders at CRL have sold more shares than they have bought.

Richard F. Wallman, Director of CRL, was the latest CRL insider to buy. They bought $386,277.50 worth of CRL stock on Feb 23, 2023.

Dig into more about who owns CRL shares here.

Can I rely on CRL as an income stream?

No, Charles River Laboratories International doesn't provide an income stream by paying out dividends.

What do other traders have to say about CRL?

One of the major reasons eToro is our favorite brokerage is because of its social trading community.

Click below to learn what other investors have to say.

Step 5: Make your CRL trade

You have two main options:

  • Market order: A market order is an order to buy or sell a security at the best price on the market.
    Market orders are generally the easiest way to buy.
  • Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
    If you want to be certain you're buying or selling at an exact price limit, use a limit order.

Click the Open button and eToro will place the order.

If you require additional help investing in stocks on eToro, click the how to video below:

Open eToro Account

Step 6: Get notifications regarding your CRL investment

Now that you own some CRL shares, you'll want to stay up-to-date on your new investment.

Create a watchlist to keep tabs on your CRL stock.

CRL Feed

How to Buy Stock in Charles River Laboratories International

To reiterate, here are the 6 steps to buy Charles River Laboratories International stock:

  1. Choose where to buy Charles River Laboratories International stock
  2. Open a brokerage account
  3. Deposit funds into your investment account
  4. Evaluate Charles River Laboratories International stock
  5. Make your CRL trade
  6. Get notifications regarding your CRL investment

If you require a online brokerage, eToro is our recommended option.

Get Started with eToro Today

If you want to keep tabs on your investment in Charles River Laboratories International, click below.

NYSE: CRL
$201.82+3.79 (+1.91%)
Updated Mar 31, 2023
Open eToro Account
NYSE: CRL
$201.82+3.79 (+1.91%)
Updated Mar 31, 2023
Open eToro Account

FAQ

How much does it cost to buy one Charles River Laboratories International share?

As of Mar 31, 2023, it costs $201.82 to buy one share of Charles River Laboratories International stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $100, you can buy 0.495 shares of CRL.

Get Started with eToro Today

Is now a good time to buy Charles River Laboratories International stock?

According to 7 Wall Street analysts who monitor Charles River Laboratories International, their consensus recommendation is to buy Charles River Laboratories International stock.

What is the best way to buy Charles River Laboratories International stock?

One way to place an order for Charles River Laboratories International stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.